2021 严重医院内感染的抗生素选择建议

2021-10-25 国外感染病相关专家组(统称) Rev Esp Quimioter

严重感染以及尤其演变的脓毒症是导致严重疾病和死亡的主要原因之一。正确的治疗是改善预后的关键。本文主要针对严重医院内感染的抗生素选择提供指导建议,涉及脓毒症早期识别,高危患者识别以及优化抗生素治疗。

中文标题:

2021 严重医院内感染的抗生素选择建议

英文标题:

Recommendations for antibiotic selection for severe nosocomial infections

发布日期:

2021-10-25

简要介绍:

严重感染以及尤其演变的脓毒症是导致严重疾病和死亡的主要原因之一。正确的治疗是改善预后的关键。本文主要针对严重医院内感染的抗生素选择提供指导建议,涉及脓毒症早期识别,高危患者识别以及优化抗生素治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 严重医院内感染的抗生素选择建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=00f4c1c002238a38, title=2021 严重医院内感染的抗生素选择建议, enTitle=Recommendations for antibiotic selection for severe nosocomial infections, guiderFrom=Rev Esp Quimioter, authorId=0, author=, summary=严重感染以及尤其演变的脓毒症是导致严重疾病和死亡的主要原因之一。正确的治疗是改善预后的关键。本文主要针对严重医院内感染的抗生素选择提供指导建议,涉及脓毒症早期识别,高危患者识别以及优化抗生素治疗。, cover=https://img.medsci.cn/20211026/1635257399060_5579292.jpg, journalId=0, articlesId=null, associationId=1273, associationName=国外感染病相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">严重感染以及尤其演变的脓毒症是导致严重疾病和死亡的主要原因之一。正确的治疗是改善预后的关键。本文主要针对严重医院内感染的抗生素选择提供指导建议,涉及脓毒症早期识别,高危患者识别以及优化抗生素治疗。</span></p>, tagList=[TagDto(tagId=47426, tagName=严重感染)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=47426, guiderKeyword=严重感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4986, appHits=298, showAppHits=0, pcHits=768, showPcHits=4687, likes=4, shares=26, comments=9, approvalStatus=1, publishedTime=Tue Oct 26 22:35:00 CST 2021, publishedTimeString=2021-10-25, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 26 22:13:07 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 17:21:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 严重医院内感染的抗生素选择建议.pdf)])
2021 严重医院内感染的抗生素选择建议.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195620, encodeId=be53119562089, content=外国文献?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a55703166, createdName=悦悦爸爸, createdTime=Mon Feb 21 10:58:47 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180285, encodeId=0902118028583, content=抗感染很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3c6445695, createdName=ms1000001767078006, createdTime=Tue Jan 04 09:09:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085584, encodeId=05f51085584f0, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLKJk6OZ0Fd4Y2kN4Eice2zLbHviazqxZYneibJcEbZVk0D2olKJdzL8f2DLqAMFxxB8K0uBGXMXSTA/132, createdBy=c43d2326406, createdName=Alberty, createdTime=Wed Dec 29 22:05:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071357, encodeId=472c10e1357e7, content=过来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8915461375, createdName=ms9000000763637162, createdTime=Thu Nov 18 11:04:50 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064254, encodeId=da901064254bb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Oct 27 06:11:56 CST 2021, time=2021-10-27, status=1, ipAttribution=)]
    2022-02-21 悦悦爸爸

    外国文献?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195620, encodeId=be53119562089, content=外国文献?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a55703166, createdName=悦悦爸爸, createdTime=Mon Feb 21 10:58:47 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180285, encodeId=0902118028583, content=抗感染很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3c6445695, createdName=ms1000001767078006, createdTime=Tue Jan 04 09:09:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085584, encodeId=05f51085584f0, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLKJk6OZ0Fd4Y2kN4Eice2zLbHviazqxZYneibJcEbZVk0D2olKJdzL8f2DLqAMFxxB8K0uBGXMXSTA/132, createdBy=c43d2326406, createdName=Alberty, createdTime=Wed Dec 29 22:05:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071357, encodeId=472c10e1357e7, content=过来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8915461375, createdName=ms9000000763637162, createdTime=Thu Nov 18 11:04:50 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064254, encodeId=da901064254bb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Oct 27 06:11:56 CST 2021, time=2021-10-27, status=1, ipAttribution=)]
    2022-01-04 ms1000001767078006

    抗感染很重要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195620, encodeId=be53119562089, content=外国文献?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a55703166, createdName=悦悦爸爸, createdTime=Mon Feb 21 10:58:47 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180285, encodeId=0902118028583, content=抗感染很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3c6445695, createdName=ms1000001767078006, createdTime=Tue Jan 04 09:09:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085584, encodeId=05f51085584f0, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLKJk6OZ0Fd4Y2kN4Eice2zLbHviazqxZYneibJcEbZVk0D2olKJdzL8f2DLqAMFxxB8K0uBGXMXSTA/132, createdBy=c43d2326406, createdName=Alberty, createdTime=Wed Dec 29 22:05:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071357, encodeId=472c10e1357e7, content=过来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8915461375, createdName=ms9000000763637162, createdTime=Thu Nov 18 11:04:50 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064254, encodeId=da901064254bb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Oct 27 06:11:56 CST 2021, time=2021-10-27, status=1, ipAttribution=)]
    2021-12-29 Alberty

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195620, encodeId=be53119562089, content=外国文献?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a55703166, createdName=悦悦爸爸, createdTime=Mon Feb 21 10:58:47 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180285, encodeId=0902118028583, content=抗感染很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3c6445695, createdName=ms1000001767078006, createdTime=Tue Jan 04 09:09:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085584, encodeId=05f51085584f0, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLKJk6OZ0Fd4Y2kN4Eice2zLbHviazqxZYneibJcEbZVk0D2olKJdzL8f2DLqAMFxxB8K0uBGXMXSTA/132, createdBy=c43d2326406, createdName=Alberty, createdTime=Wed Dec 29 22:05:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071357, encodeId=472c10e1357e7, content=过来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8915461375, createdName=ms9000000763637162, createdTime=Thu Nov 18 11:04:50 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064254, encodeId=da901064254bb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Oct 27 06:11:56 CST 2021, time=2021-10-27, status=1, ipAttribution=)]
    2021-11-18 ms9000000763637162

    过来学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1195620, encodeId=be53119562089, content=外国文献?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a55703166, createdName=悦悦爸爸, createdTime=Mon Feb 21 10:58:47 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180285, encodeId=0902118028583, content=抗感染很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3c6445695, createdName=ms1000001767078006, createdTime=Tue Jan 04 09:09:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085584, encodeId=05f51085584f0, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLKJk6OZ0Fd4Y2kN4Eice2zLbHviazqxZYneibJcEbZVk0D2olKJdzL8f2DLqAMFxxB8K0uBGXMXSTA/132, createdBy=c43d2326406, createdName=Alberty, createdTime=Wed Dec 29 22:05:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071357, encodeId=472c10e1357e7, content=过来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8915461375, createdName=ms9000000763637162, createdTime=Thu Nov 18 11:04:50 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064254, encodeId=da901064254bb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Oct 27 06:11:56 CST 2021, time=2021-10-27, status=1, ipAttribution=)]
    2021-10-27 未来将来

    学习一下

    0